ClinTec Expands U.S. Capabilities

ClinTec International has expanded into the U.S. market with the launch of its New York office and the appointment of Susan Pavone, associate director of U.S. Business Operations. Ms. Pavone has more than 20 years of industry experience, including eight years of successfully managing the business operations of Pfizer’s internal CRO.

The company’s U.S. operations will focus on providing clients with access to global clinical research capabilities through a single partner. President and chief executive officer of ClinTec, Dr. Rabinder Buttar, remarked, “We have established a strong presence in the international marketplace by placing expert clinical research staff in all key emerging, and established markets. ClinTec’s ability to harness global strength, coupled with local, on the ground expertise, will be of great value to U.S. pharmaceutical companies. Ms. Pavone has extensive knowledge of international clinical research and the new U.S. facilities will prove an invaluable asset to American companies looking to tap into our globalised resources and expertise.”